The Mesothelioma Center News – Page 31
-
news
Research & Clinical TrialsThe plant-based substance curcumin could soon be included in the multidisciplinary treatment of malignant mesothelioma, according to a recent multicenter, international study review. Curcumin,… -
news
Research & Clinical TrialsUPenn Research with Mesothelioma Blood Test Shows Promise
Scientist Ian Blair at the University of Pennsylvania School of Medicine believes his team is close to identifying the variant of a blood-based biomarker… -
news
Research & Clinical TrialsMesothelioma Clinical Trial Testing New INBRX-109 Antibody
A new clinical trial is testing an innovative approach to immunotherapy that could change the way antibodies target pleural mesothelioma tumors. Researchers at… -
news
Treatment & DoctorsCoronavirus Postpones Mesothelioma Symposium
The Mesothelioma Applied Research Foundation has postponed its annual International Symposium on Malignant Mesothelioma next month because of the COVID-19 virus, commonly known as… -
news
Asbestos Exposure & BansRevlon Named in Talc-Mesothelioma Lawsuit
Revlon Inc. on Tuesday became the latest corporation hit with a lawsuit alleging asbestos-contaminated talc in its cosmetic products caused mesothelioma cancer in a… -
news
Research & Clinical TrialsMesothelioma Clinical Trial Involves Immunotherapy Before Surgery
Three of the country’s leading cancer centers have opened a collaborative clinical trial that potentially could change surgical treatment of mesothelioma. Researchers will… -
news
Research & Clinical TrialsMesothelioma Gene Therapy Trial Shows ‘Real Potential’
Gene therapy is moving closer to becoming part of standard-of-care treatment for pleural mesothelioma, according to the latest multicenter clinical trial. The phase… -
news
Treatment & DoctorsAlternative to Alimta Coming for Mesothelioma Patients
The U.S. Food and Drug Administration has granted final approval of Pemfexy, a new brand of the chemotherapy drug pemetrexed, to combat malignant… -
news
Asbestos Exposure & BansFDA Moves Closer to Standardized Testing for Asbestos in Talc
The U.S. Food and Drug Administration moved closer on Tuesday to formulating standardized testing of talc-based products for the presence of toxic asbestos… -
news
Research & Clinical TrialsONCOS-102 Shows Promise in Combination Mesothelioma Treatment
ONCOS-102, a promising immunotherapy vaccine, is moving closer to becoming a part of future first-line treatment for mesothelioma. Early clinical trial results…